Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.
Gottardi M, Mosna F, de Angeli S, Papayannidis C, Candoni A, Clavio M, Tecchio C, Piccin A, dell'Orto MC, Benedetti F, Martinelli G, Gherlinzoni F.
Gottardi M, et al. Among authors: de angeli s.
Hematol Rep. 2017 Sep 26;9(3):7029. doi: 10.4081/hr.2017.7028. eCollection 2017 Sep 26.
Hematol Rep. 2017.
PMID: 29071049
Free PMC article.
No abstract available.